The company's strong cash position and reduced burn rate provide a long runway, but the lack of a disclosed pipeline or near-term catalyst means the stock will likely trade on any future acquisition or in-licensing announcements. Monitor for any definitive transaction agreements or strategic updates.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · May 15 $8.07entry
- T+1 · 6mo ago +0.74%α +0.81% · $8.13
- T+5 · 6mo ago +1.36%α +0.40% · $8.18
- T+20 · 5mo ago −1.86%α −3.98% · $7.92
- T+60 · 3mo ago −7.19%α −11.70% · $7.49
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Instil Bio reported Q1 2026 GAAP EPS of -$0.62, in line with the consensus estimate of -$0.59 (within the ±2% threshold). The company has $74.7M in cash, expected to fund operations beyond 2027, and is actively evaluating acquisition and in-licensing opportunities, though no specific transactions have been announced.
Key Financial Metrics
Key Facts
- GAAP net loss per share of $0.62 for Q1 2026, compared to $4.32 in Q1 2025
- Non-GAAP net loss per share of $0.32 for Q1 2026, compared to $1.32 in Q1 2025
- Cash, cash equivalents, restricted cash and marketable securities of $74.7M as of March 31, 2026
- Cash runway expected to fund current operating plan beyond 2027
- Company is actively evaluating acquisition and in-licensing opportunities
- Research and development expenses decreased to $0.7M from $5.4M year-over-year
- Restructuring and impairment charges of $1.0M, down from $16.1M year-over-year
Financial Impact
Net loss improved to $4.2M from $28.2M year-over-year; cash burn rate reduced significantly
Risk Factors
- No assurance that any acquisition or in-licensing transaction will materialize
- Company currently has no disclosed pipeline or revenue-generating products
- Forward-looking statements subject to risks including interest rates, inflation, and tariffs
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3295719 |
Track record
8 reports on TIL
Filters
- Nov 16, 2026today 8-K Neutral 4/10 Entry $6.22 Now $5.75 −7.56% settles Dec 15
- Aug 13, 202613w ago Press Release Neutral 4/10 No price data
- Aug 13, 202613w ago 8-K Neutral 4/10 Entry $7.38 to $7.45 Now $5.75 −22.09% ▲ +0.95% +2.94% vs SPY
- May 15, 202626w ago 8-K Neutral 4/10 No price data
- May 15, 202626w ago Press Release Neutral 4/10 Viewing Entry $8.07 to $7.92 Now $5.75 −28.75% ▼ −1.86% −3.98% vs SPY
- Apr 24, 202629w ago DEFA14A Neutral 2/10 Entry $8.13 to $8.12 Now $5.75 −29.27% ▼ −0.12% −5.08% vs SPY
- Apr 3, 202632w ago 8-K Neutral 4/10 Entry $8.46 to $7.84 Now $5.75 −32.03% ▼ −7.33% −16.31% vs SPY
- Mar 27, 202633w ago Press Release Mixed 5/10 Entry $7.79 to $8.13 Now $5.75 −26.19% ▲ +4.36% −8.38% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers